175 related articles for article (PubMed ID: 37002577)
1. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies.
Pandey P; Khan F; Upadhyay TK; Seungjoon M; Park MN; Kim B
Biomed Pharmacother; 2023 May; 161():114491. PubMed ID: 37002577
[TBL] [Abstract][Full Text] [Related]
2. Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review.
Zou X; Tang XY; Qu ZY; Sun ZW; Ji CF; Li YJ; Guo SD
Int J Biol Macromol; 2022 Mar; 202():539-557. PubMed ID: 35074329
[TBL] [Abstract][Full Text] [Related]
3. The PDGF/PDGFR pathway as a drug target.
Papadopoulos N; Lennartsson J
Mol Aspects Med; 2018 Aug; 62():75-88. PubMed ID: 29137923
[TBL] [Abstract][Full Text] [Related]
4. Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis.
Cao Y
Trends Mol Med; 2013 Aug; 19(8):460-73. PubMed ID: 23773831
[TBL] [Abstract][Full Text] [Related]
5. PDGF/PDGFR signaling and targeting in cancer growth and progression: Focus on tumor microenvironment and cancer-associated fibroblasts.
Gialeli C; Nikitovic D; Kletsas D; Theocharis AD; Tzanakakis GN; Karamanos NK
Curr Pharm Des; 2014; 20(17):2843-8. PubMed ID: 23944365
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
7. PDGFs and their receptors.
Kazlauskas A
Gene; 2017 May; 614():1-7. PubMed ID: 28267575
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.
Appiah-Kubi K; Wang Y; Qian H; Wu M; Yao X; Wu Y; Chen Y
Tumour Biol; 2016 Aug; 37(8):10053-66. PubMed ID: 27193823
[TBL] [Abstract][Full Text] [Related]
10. The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer.
Wang Y; Appiah-Kubi K; Wu M; Yao X; Qian H; Wu Y; Chen Y
Growth Factors; 2016 Feb; 34(1-2):64-71. PubMed ID: 27170215
[TBL] [Abstract][Full Text] [Related]
11. Role of platelet-derived growth factors in physiology and medicine.
Andrae J; Gallini R; Betsholtz C
Genes Dev; 2008 May; 22(10):1276-312. PubMed ID: 18483217
[TBL] [Abstract][Full Text] [Related]
12. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions.
Heidaran MA; Beeler JF; Yu JC; Ishibashi T; LaRochelle WJ; Pierce JH; Aaronson SA
J Biol Chem; 1993 May; 268(13):9287-95. PubMed ID: 8387491
[TBL] [Abstract][Full Text] [Related]
13. The Role of PDGFs and PDGFRs in Colorectal Cancer.
Manzat Saplacan RM; Balacescu L; Gherman C; Chira RI; Craiu A; Mircea PA; Lisencu C; Balacescu O
Mediators Inflamm; 2017; 2017():4708076. PubMed ID: 28163397
[No Abstract] [Full Text] [Related]
14. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: correlations with clinicopathological features and cytogenetic analysis.
Figarella-Branger D; Vagner-Capodano AM; Bouillot P; Graziani N; Gambarelli D; Devictor B; Zattara-Cannoni H; Bianco N; Grisoli F; Pellissier JF
Neuropathol Appl Neurobiol; 1994 Oct; 20(5):439-47. PubMed ID: 7531297
[TBL] [Abstract][Full Text] [Related]
17. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.
Alexandru O; Sevastre AS; Castro J; Artene SA; Tache DE; Purcaru OS; Sfredel V; Tataranu LG; Dricu A
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547056
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
[TBL] [Abstract][Full Text] [Related]
19. PDGF receptors are activated in human epiretinal membranes.
Cui J; Lei H; Samad A; Basavanthappa S; Maberley D; Matsubara J; Kazlauskas A
Exp Eye Res; 2009 Mar; 88(3):438-44. PubMed ID: 19032953
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
McGary EC; Weber K; Mills L; Doucet M; Lewis V; Lev DC; Fidler IJ; Bar-Eli M
Clin Cancer Res; 2002 Nov; 8(11):3584-91. PubMed ID: 12429650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
